Modulation of osteoclast formation

Biochemical and Biophysical Research Communications

Volumn 328, Issue 3, 2005, Pages 739-745

  Quinn, Julian M W ^a   Gillespie, Matthew T ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; CYTOKINE; ESTROGEN; INTERFERON; LECTIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOCLAST INHIBITORY LIGAND; OSTEOPROTEGERIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; HUMAN; MACROPHAGE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 13444306371     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.076     Document Type: Review

References (56)

1. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
2. J.M. Quinn, N.J. Horwood, J. Elliott, M.T. Gillespie, and T.J. Martin Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation J. Bone Miner. Res. 15 2000 1459 1466
3. N.J. Horwood, V. Kartsogiannis, J.M. Quinn, E. Romas, T.J. Martin, and M.T. Gillespie Activated T lymphocytes support osteoclast formation in vitro Biochem. Biophys. Res. Commun. 265 1999 144 150
4. N. Calvani, F. Silvestris, P. Cafforio, and F. Dammacco Osteoclast-like cell formation by circulating myeloma B lymphocytes: role of RANK-L Leuk. Lymphoma 45 2004 377 380
5. T. Yamane, T. Kunisada, H. Yamazaki, T. Era, T. Nakano, and S.I. Hayashi Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent Blood 90 1997 3516 3523
6. H. Yoshida, S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, and L.D. Shultz The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene Nature 345 1990 442 444
7. M.M. Tondravi, S.R. McKercher, K. Anderson, J.M. Erdmann, M. Quiroz, R. Maki, and S.L. Teitelbaum Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 Nature 386 1997 81 84
8. Y.Y. Kong, H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, C. Capparelli, S. Morony, A.J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C.R. Dunstan, D.L. Lacey, T.W. Mak, W.J. Boyle, and J.M. Penninger OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
9. D.L. Lacey, E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y.X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W.J. Boyle Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 1998 165 176
10. K. Kobayashi, N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, T. Morinaga, K. Higashio, T.J. Martin, and T. Suda Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J. Exp. Med. 191 2000 275 286
11. J. Edwards, S. Sun, C. Shipman, N. Athanasou, and A. Sabokbar LIGHT (TNFSF14), a novel mediator of normal and pathological bone resorption J. Bone Miner. Res. 19 2004 S9
12. Y.Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, T. Wong, G. Campagnuolo, E. Moran, E.R. Bogoch, G. Van, L.T. Nguyen, P.S. Ohashi, D.L. Lacey, E. Fish, W.J. Boyle, and J.M. Penninger Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
13. F. Arai, T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D.M. Anderson, and T. Suda Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors J. Exp. Med. 190 1999 1741 1754
14. N.J. Horwood, J. Elliott, T.J. Martin, and M.T. Gillespie Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells Endocrinology 139 1998 4743 4746
15. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, and W.J. Boyle Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
16. N.L. Fazzalari, J.S. Kuliwaba, G.J. Atkins, M.R. Forwood, and D.M. Findlay The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis J. Bone Miner. Res. 16 2001 1015 1027
17. N.A. Sims, J.R. Green, M. Glatt, S. Schlict, T.J. Martin, M.T. Gillespie, and E. Romas Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis Arthritis Rheum. 50 2004 2338 2346
18. G. Schett, K. Redlich, S. Hayer, J. Zwerina, B. Bolon, C. Dunstan, B. Gortz, A. Schulz, H. Bergmeister, G. Kollias, G. Steiner, and J.S. Smolen Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice Arthritis Rheum. 48 2003 2042 2051
19. J. Zwerina, S. Hayer, M. Tohidast-Akrad, H. Bergmeister, K. Redlich, U. Feige, C. Dunstan, G. Kollias, G. Steiner, J. Smolen, and G. Schett Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction Arthritis Rheum. 50 2004 277 290
20. B.O. Oyajobi, D.M. Anderson, K. Traianedes, P.J. Williams, T. Yoneda, and G.R. Mundy Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy Cancer Res. 61 2001 2572 2578
21. M.R. McClung, E.M. Lewiecki, M.A. Bolognese, G. Woodson, A. Moffett, M. Peacock, P.D. Miller, S. Lederman, C.H. Chesnut, and R. Murphy AMG 162 increases bone mineral density (BMD) within 1 month in postmenopausal women with low BMD J. Bone Miner. Res. 19 2004 S20
22. J.M. Quinn, J. Elliott, M.T. Gillespie, and T.J. Martin A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro Endocrinology 139 1998 4424 4427
23. N. Udagawa, N.J. Horwood, J. Elliott, A. Mackay, J. Owens, H. Okamura, M. Kurimoto, T.J. Chambers, T.J. Martin, and M.T. Gillespie Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation J. Exp. Med. 185 1997 1005 1012
24. D. Mirosavljevic, J.M. Quinn, J. Elliott, N.J. Horwood, T.J. Martin, and M.T. Gillespie T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis J. Bone Miner. Res. 18 2003 984 993
25. T. Miyamoto, O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D.M. Anderson, and T. Suda Bifurcation of osteoclasts and dendritic cells from common progenitors Blood 98 2001 2544 2554
26. J. Hodge, M.A. Kirkland, C.J. Aitken, C.M. Waugh, D.E. Myers, C.M. Lopez, B.E. Adams, and G.C. Nicholson Osteoclastic potential of human CFU-GM: bisphasic effect of GM-CSF J. Bone Miner. Res. 19 2003 2057 2064
27. J.M. Quinn, K. Itoh, N. Udagawa, K. Hausler, H. Yasuda, N. Shima, A. Mizuno, K. Higashio, N. Takahashi, T. Suda, T.J. Martin, and M.T. Gillespie Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions J. Bone Miner. Res. 16 2001 1787 1794
28. J.M. Quinn, G.A. Whitty, R.J. Byrne, M.T. Gillespie, and J.A. Hamilton The generation of highly enriched osteoclast-lineage cell populations Bone 30 2002 164 170
29. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E.F. Wagner, T.W. Mak, T. Kodama, and T. Taniguchi Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev. Cell 3 2002 889 901
30. A.E. Grigoriadis, Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, and E.F. Wagner c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science 266 1994 443 448
31. T. Akune, S. Ohba, S. Kamekura, M. Yamaguchi, U.I. Chung, N. Kubota, Y. Terauchi, Y. Harada, Y. Azuma, K. Nakamura, T. Kadowaki, and H. Kawaguchi PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors J. Clin. Invest. 113 2004 846 855
32. M.J. Rogers New insights into the molecular mechanisms of action of bisphosphonates Curr. Pharm. Des. 9 2003 2643 2658
33. J.S. Finkelstein, A. Hayes, J.L. Hunzelman, J.J. Wyland, H. Lee, and R.M. Neer The effects of parathyroid hormone, alendronate, or both in men with osteoporosis N. Engl. J. Med. 349 2003 1216 1226
34. P.M. Sexton, D.M. Findlay, and T.J. Martin Calcitonin Curr. Med. Chem. 6 1999 1067 1093
35. S. Wada, N. Udagawa, T. Akatsu, N. Nagata, T.J. Martin, and D.M. Findlay Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts [see comments] Endocrinology 138 1997 521 529
36. F.M. Collier, W.H. Huang, W.R. Holloway, J.M. Hodge, M.T. Gillespie, L.L. Daniels, M.H. Zheng, and G.C. Nicholson Osteoclasts from human giant cell tumors of bone lack estrogen receptors Endocrinology 139 1998 1258 1267
37. S.M. Khapli, L.S. Mangashetti, S.D. Yogesha, and M.R. Wani IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage J. Immunol. 171 2003 142 151
38. A.C. Bendixen, N.K. Shevde, K.M. Dienger, T.M. Willson, C.D. Funk, and J.W. Pike IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1 Proc. Natl. Acad. Sci. USA 98 2001 2443 2448
39. J.M. Owens, A.C. Gallagher, and T.J. Chambers IL-10 modulates formation of osteoclasts in murine hemopoietic cultures J. Immunol. 157 1996 936 940
40. G. Gorny, A. Shaw, and M.J. Oursler IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro Exp. Cell Res. 294 2004 149 158
41. J. Ahlen, S. Andersson, H. Mukohyama, C. Roth, A. Backman, H.H. Conaway, and U.H. Lerner Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones Bone 31 2002 242 251
42. N.J. Horwood, J. Elliott, T.J. Martin, and M.T. Gillespie IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro J. Immunol. 166 2001 4915 4921
43. N.J. Horwood, N. Udagawa, J. Elliott, D. Grail, H. Okamura, M. Kurimoto, A.R. Dunn, T. Martin, and M.T. Gillespie Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor J. Clin. Invest. 101 1998 595 603
44. A. Erlebacher, and R. Derynck Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype J. Cell Biol. 132 1996 195 210
45. E. Filvaroff, A. Erlebacher, J. Ye, S.E. Gitelman, J. Lotz, M. Heillman, and R. Derynck Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass Development 126 1999 4267 4279
46. R.O. Oreffo, G.R. Mundy, S.M. Seyedin, and L.F. Bonewald Activation of the bone-derived latent TGF beta complex by isolated osteoclasts Biochem. Biophys. Res. Commun. 158 1989 817 823
47. H. Takayanagi, S. Kim, and T. Taniguchi Signaling crosstalk between RANKL and interferons in osteoclast differentiation Arthritis Res. 4 3 2002 S227 S232
48. K. Fuller, J.M. Owens, C.J. Jagger, A. Wilson, R. Moss, and T.J. Chambers Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts J. Exp. Med. 178 1993 1733 1744
49. H. Zhou, V. Kartsogiannis, Y.S. Hu, J. Elliott, J.M. Quinn, W.J. McKinstry, M.T. Gillespie, and K.W. Ng A novel osteoblast-derived c-type lectin that inhibits osteoclast formation J. Biol. Chem. 276 2001 14916 14923
50. H. Zhou, V. Kartsogiannis, J.M. Quinn, C. Ly, C. Gange, J. Elliott, K.W. Ng, and M.T. Gillespie Osteoclast inhibitory lectin-a family of new osteoclast inhibitors J. Biol. Chem. 277 2002 48808 48815
51. Y.S. Hu, H. Zhou, D.E. Myers, J.M.W. Quinn, G.J. Atkins, C. Ly, C. Gange, V. Kartsogiannis, J. Elliott, P. Kostakis, A.C.W. Zannettino, B. Cromer, W.J. McKinstry, D.M. Findlay, M.T. Gillespie, and K.W. Ng Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts J. Bone Miner. Res. 19 2004 89 99
52. A. Nakamura, J.M.W. Quinn, N.A. Sims, C.T. Gange, H. Zhou, V. Kartsogiannis, E.H. Allan, T.J. Martin, K.W. Ng, and M.T. Gillespie Osteoclast inhibitory lectin (OCIL) is required for normal bone remodelling in vivo and inhibits osteoblast function in vitro J. Bone Miner. Res. 19 2004 S8
53. C.T. Gange, J.M. Quinn, H. Zhou, V. Kartsogiannis, M.T. Gillespie, and K.W. Ng Characterization of sugar binding by osteoclast inhibitory lectin J. Biol. Chem. 279 2004 29043 29049
54. J.R. Carlyle, A.M. Jamieson, S. Gasser, C.S. Clingan, H. Arase, and D.H. Raulet Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors Proc. Natl. Acad. Sci. USA 101 2004 3527 3532
55. K. Iizuka, O.V. Naidenko, B.F. Plougastel, D.H. Fremont, and W.M. Yokoyama Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors Nat. Immunol. 4 2003 801 807
56. T. Koga, M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, T. Taniguchi, H. Takayanagi, and T. Takai Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 2004 758 763